EMA recommends 30 veterinary medicines for marketing authorisation in 2025

The European Medicines Agency (EMA) has published an overview of its key recommendations of 2025 regarding the authorisation and safety monitoring of veterinary medicines.

In 2025, EMA recommended 30 veterinary medicines for marketing authorisation - the highest number of recommendations ever in a year for a second consecutive year. This suggests a sustained high interest in the development of veterinary medicines and the positive impact of the Veterinary Medicines Regulation in fostering product innovation. The Regulation came into force in January 2022.

Among the 30 medicines recommended for marketing authorisation, 16 were vaccines, including seven that were approved under exceptional circumstances to respond to animal health emergencies. Five vaccines were developed through a biotechnological process.

A selection of these recommendations can be found in the veterinary medicines highlights document published on January 19.